By integrating multi-omics analyses, machine learning modeling, single-cell RNA sequencing and in vitro validation, we identified distinct PRG-related molecular subtypes, constructed a robust prognostic scoring model, and revealed COL8A1 as a key PRG that may contribute to tumor progression and immune evasion. The gene discussed is COL8A1; the disease is neoplasm.